AMD - AGE-RELATED MACULAR DEGENERATION
Clinical trials for AMD - AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AMD - AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AMD - AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for macular degeneration enters first human tests
Disease control Recruiting nowThis early-stage study tests an oral drug called ABF-101 in healthy adults and people with age-related macular degeneration (AMD). The main goal is to check safety and how the body processes the drug. If successful, it could lead to a new way to control AMD, a leading cause of vi…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Eye study seeks to predict vision recovery after bleeding
Knowledge-focused Recruiting nowThis study looks at 60 people with age-related macular degeneration who had bleeding under the retina. Researchers want to see if the type of abnormal blood vessels affects how well vision recovers after a gas bubble treatment. The goal is to find which patients are most likely t…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Sponsor: Marco Mazzola • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC